MedPath

Evaluation of L-carnitine effect on prevention of chemotherapy-induced oral mucositis , A prospective, randomized, double-blind, controlled trial

Not Applicable
Recruiting
Conditions
mucositis.
Oral mucositis (ulcerative)
Registration Number
IRCT201102265914N1
Lead Sponsor
Vice chancellor for research, Urmia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Exclusion criteria: the risk of side effects such as nausea or whenever the patient refuse to participate in the study
Inclusion criteria of the study: bedridden in Oncology unit, consent to participate in the study, without using drugs or any vitamin and mineral carnitine in the past 8 weeks, aged over 18 years

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oral mucositis. Timepoint: weekly. Method of measurement: observation.;CBC. Timepoint: weekly. Method of measurement: blood sample.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath